This is not the most recent version of the article. View current version (17 DEC 2013)

Intervention Protocol

Pharmacologic treatment for memory disorder in multiple sclerosis

  1. Dian He2,
  2. Hongyu Zhou1,*,
  3. Duan Guo1,
  4. Zilong Hao1,
  5. Bo Wu1

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 8 DEC 2010

Assessed as up-to-date: 29 MAY 2010

DOI: 10.1002/14651858.CD008876


How to Cite

He D, Zhou H, Guo D, Hao Z, Wu B. Pharmacologic treatment for memory disorder in multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD008876. DOI: 10.1002/14651858.CD008876.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Neurology, Chengdu, Sichuan, China

  2. 2

    Affiliated Hospital of Guiyang Medical College, Department of Neurology, Guiyang, Guizhou Province, China

*Hongyu Zhou, Department of Neurology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. Hyzhou98@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 DEC 2010

SEARCH

This is not the most recent version of the article. View current version (17 DEC 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the absolute and comparative efficacy, tolerability and safety of pharmacologic treatments for memory disorder in patients with MS.